Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMZF0DK)

• Drug Name: Aminopyrimidine derivative 6 Drug Info
• Synonyms: PMID26293650-Compound-43
• Cross-matching ID:
  PubChem CID: 51357830
  TTD Drug ID: DMZF0DK

Molecule-Related Drug Atlas

Drug(s) Targeting NF-kappa-B-activating kinase (TBK1)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
PMID26293650-Compound-34	DMHXT12	N. A.	N. A.	Patented	[1]
PMID26293650-Compound-35	DMPG8MF	N. A.	N. A.	Patented	[1]
Pyrimidinyl compound 4	DM53O9Y	N. A.	N. A.	Patented	[1]
Aminopyrimidine derivative 10	DM2TF64	N. A.	N. A.	Patented	[1]
Pyrimidinyl compound 7	DMMYW2L	N. A.	N. A.	Patented	[1]
Pyrimidinyl compound 1	DMYKHQ8	N. A.	N. A.	Patented	[1]
Aminopyrimidine derivative 7	DMW98RI	N. A.	N. A.	Patented	[1]
Pyrimidinyl compound 3	DMOE2FZ	N. A.	N. A.	Patented	[1]
Aminopyrimidine derivative 9	DM5VRXW	N. A.	N. A.	Patented	[1]
Pyrimidinyl compound 2	DM9TW5O	N. A.	N. A.	Patented	[1]

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
NF-kappa-B-activating kinase (TBK1)	TTH5TC2	TBK1_HUMAN	Inhibitor	[1]

References

• [1] TBK1 inhibitors: a review of patent literature (2011 - 2014).Expert Opin Ther Pat. 2015;25(12):1385-96.